215 related articles for article (PubMed ID: 21794976)
1. Resveratrol inhibits the epidermal growth factor-induced epithelial mesenchymal transition in MCF-7 cells.
Vergara D; Valente CM; Tinelli A; Siciliano C; Lorusso V; Acierno R; Giovinazzo G; Santino A; Storelli C; Maffia M
Cancer Lett; 2011 Nov; 310(1):1-8. PubMed ID: 21794976
[TBL] [Abstract][Full Text] [Related]
2. Src promotes EGF-induced epithelial-to-mesenchymal transition and migration in gastric cancer cells by upregulating ZEB1 and ZEB2 through AKT.
Zhao L; Li X; Song N; Li A; Hou K; Qu X; Che X; Liu Y
Cell Biol Int; 2018 Mar; 42(3):294-302. PubMed ID: 29052277
[TBL] [Abstract][Full Text] [Related]
3. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
[TBL] [Abstract][Full Text] [Related]
4. Epithelial to mesenchymal transition is associated with rapamycin resistance.
Holder AM; Akcakanat A; Adkins F; Evans K; Chen H; Wei C; Milton DR; Li Y; Do KA; Janku F; Meric-Bernstam F
Oncotarget; 2015 Aug; 6(23):19500-13. PubMed ID: 25944619
[TBL] [Abstract][Full Text] [Related]
5. Activation of histamine H4 receptors decreases epithelial-to-mesenchymal transition progress by inhibiting transforming growth factor-β1 signalling pathway in non-small cell lung cancer.
Cai WK; Hu J; Li T; Meng JR; Ma X; Yin SJ; Zhao CH; He GH; Xu GL
Eur J Cancer; 2014 Apr; 50(6):1195-206. PubMed ID: 24447834
[TBL] [Abstract][Full Text] [Related]
6. IBP regulates epithelial-to-mesenchymal transition and the motility of breast cancer cells via Rac1, RhoA and Cdc42 signaling pathways.
Zhang Z; Yang M; Chen R; Su W; Li P; Chen S; Chen Z; Chen A; Li S; Hu C
Oncogene; 2014 Jun; 33(26):3374-82. PubMed ID: 23975422
[TBL] [Abstract][Full Text] [Related]
7. Pterostilbene inhibits triple-negative breast cancer metastasis via inducing microRNA-205 expression and negatively modulates epithelial-to-mesenchymal transition.
Su CM; Lee WH; Wu AT; Lin YK; Wang LS; Wu CH; Yeh CT
J Nutr Biochem; 2015 Jun; 26(6):675-85. PubMed ID: 25792283
[TBL] [Abstract][Full Text] [Related]
8. Targeting FoxM1 inhibits proliferation, invasion and migration of nasopharyngeal carcinoma through the epithelial‑to-mesenchymal transition pathway.
Yu C; Chen L; Yie L; Wei L; Wen T; Liu Y; Chen H
Oncol Rep; 2015 May; 33(5):2402-10. PubMed ID: 25738652
[TBL] [Abstract][Full Text] [Related]
9. A novel anti‑cancer effect of resveratrol: reversal of epithelial‑mesenchymal transition in prostate cancer cells.
Li J; Chong T; Wang Z; Chen H; Li H; Cao J; Zhang P; Li H
Mol Med Rep; 2014 Oct; 10(4):1717-24. PubMed ID: 25069516
[TBL] [Abstract][Full Text] [Related]
10. Targeting the Nuclear Cathepsin L CCAAT Displacement Protein/Cut Homeobox Transcription Factor-Epithelial Mesenchymal Transition Pathway in Prostate and Breast Cancer Cells with the Z-FY-CHO Inhibitor.
Burton LJ; Dougan J; Jones J; Smith BN; Randle D; Henderson V; Odero-Marah VA
Mol Cell Biol; 2017 Mar; 37(5):. PubMed ID: 27956696
[TBL] [Abstract][Full Text] [Related]
11. Phosphoglucose isomerase/autocrine motility factor mediates epithelial-mesenchymal transition regulated by miR-200 in breast cancer cells.
Ahmad A; Aboukameel A; Kong D; Wang Z; Sethi S; Chen W; Sarkar FH; Raz A
Cancer Res; 2011 May; 71(9):3400-9. PubMed ID: 21389093
[TBL] [Abstract][Full Text] [Related]
12. Fra-1/AP-1 induces EMT in mammary epithelial cells by modulating Zeb1/2 and TGFβ expression.
Bakiri L; Macho-Maschler S; Custic I; Niemiec J; Guío-Carrión A; Hasenfuss SC; Eger A; Müller M; Beug H; Wagner EF
Cell Death Differ; 2015 Feb; 22(2):336-50. PubMed ID: 25301070
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol inhibits TGF-β1-induced epithelial-to-mesenchymal transition and suppresses lung cancer invasion and metastasis.
Wang H; Zhang H; Tang L; Chen H; Wu C; Zhao M; Yang Y; Chen X; Liu G
Toxicology; 2013 Jan; 303():139-46. PubMed ID: 23146760
[TBL] [Abstract][Full Text] [Related]
14. The P2RY2 Receptor Induces Carcinoma Cell Migration and EMT Through Cross-Talk With Epidermal Growth Factor Receptor.
Martínez-Ramírez AS; Garay E; García-Carrancá A; Vázquez-Cuevas FG
J Cell Biochem; 2016 Apr; 117(4):1016-26. PubMed ID: 26443721
[TBL] [Abstract][Full Text] [Related]
15. The putative tumor suppressor VILIP-1 counteracts epidermal growth factor-induced epidermal-mesenchymal transition in squamous carcinoma cells.
Schönrath K; Klein-Szanto AJ; Braunewell KH
PLoS One; 2012; 7(3):e33116. PubMed ID: 22479362
[TBL] [Abstract][Full Text] [Related]
16. ZEB1-responsive genes in non-small cell lung cancer.
Gemmill RM; Roche J; Potiron VA; Nasarre P; Mitas M; Coldren CD; Helfrich BA; Garrett-Mayer E; Bunn PA; Drabkin HA
Cancer Lett; 2011 Jan; 300(1):66-78. PubMed ID: 20980099
[TBL] [Abstract][Full Text] [Related]
17. Ets1 and ESE1 reciprocally regulate expression of ZEB1/ZEB2, dependent on ERK1/2 activity, in breast cancer cells.
Sinh ND; Endo K; Miyazawa K; Saitoh M
Cancer Sci; 2017 May; 108(5):952-960. PubMed ID: 28247944
[TBL] [Abstract][Full Text] [Related]
18. EGF induces epithelial-mesenchymal transition through phospho-Smad2/3-Snail signaling pathway in breast cancer cells.
Kim J; Kong J; Chang H; Kim H; Kim A
Oncotarget; 2016 Dec; 7(51):85021-85032. PubMed ID: 27829223
[TBL] [Abstract][Full Text] [Related]
19. Epithelial-mesenchymal transition is necessary for acquired resistance to cisplatin and increases the metastatic potential of nasopharyngeal carcinoma cells.
Zhang P; Liu H; Xia F; Zhang QW; Zhang YY; Zhao Q; Chao ZH; Jiang ZW; Jiang CC
Int J Mol Med; 2014 Jan; 33(1):151-9. PubMed ID: 24173500
[TBL] [Abstract][Full Text] [Related]
20. Loss of the polycomb protein Mel-18 enhances the epithelial-mesenchymal transition by ZEB1 and ZEB2 expression through the downregulation of miR-205 in breast cancer.
Lee JY; Park MK; Park JH; Lee HJ; Shin DH; Kang Y; Lee CH; Kong G
Oncogene; 2014 Mar; 33(10):1325-35. PubMed ID: 23474752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
